The long‐term direct and indirect economic burden among Parkinson's disease caregivers in the United States

por Martinez‐Martin, Pablo, Macaulay, Dendy, Jalundhwala, Yash J., Mu, Fan, Ohashi, Erika, Marshall, Thomas, Sail, Kavita
Publicado 2018

Systematic review and comparison of pharmacologic therapies for neuropathic pain associated with spinal cord injury

por Snedecor, Sonya J, Sudharshan, Lavanya, Cappelleri, Joseph C, Sadosky, Alesia, Desai, Pooja, Jalundhwala, Yash J, Botteman, Marc
Publicado 2013

Long-Term Persistence and Monotherapy with Device-Aided Therapies: A Retrospective Analysis of an Israeli Cohort of Patients with Advanced Parkinson’s Disease

por Thaler, Avner, Barer, Yael, Gross, Ruth, Cohen, Raanan, Bergmann, Lars, Jalundhwala, Yash J., Giladi, Nir, Chodick, Gabriel, Shalev, Varda, Gurevich, Tanya
Publicado 2022

Use of a medication-based algorithm to identify advanced Parkinson's disease in administrative claims data: Associations with claims-based indicators of disease severity

por Dahodwala, Nabila, Pettit, Amy R., Jahnke, Jordan, Li, Pengxiang, Ladage, Vrushabh P., Kandukuri, Prasanna L., Zamudio, Jorge, Jalundhwala, Yash J., Doshi, Jalpa A.
Publicado 2020

The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on ‘Off’-time in Patients with Advanced Parkinson’s Disease: A Systematic Review

por Antonini, Angelo, Odin, Per, Pahwa, Rajesh, Aldred, Jason, Alobaidi, Ali, Jalundhwala, Yash J., Kukreja, Pavnit, Bergmann, Lars, Inguva, Sushmitha, Bao, Yanjun, Chaudhuri, K. Ray
Publicado 2021

Effect of Levodopa‐carbidopa Intestinal Gel on Non‐motor Symptoms in Patients with Advanced Parkinson's Disease

por Standaert, David G., Rodriguez, Ramon L., Slevin, John T., Lobatz, Michael, Eaton, Susan, Chatamra, Krai, Facheris, Maurizio F., Hall, Coleen, Sail, Kavita, Jalundhwala, Yash J., Benesh, Janet
Publicado 2017

Patterns of Daily Motor-Symptom Control with Carbidopa/Levodopa Enteral Suspension Versus Oral Carbidopa/Levodopa Therapy in Advanced Parkinson’s Disease: Clinical Trial Post Hoc A...

por Pahwa, Rajesh, Aldred, Jason, Gupta, Niodita, Terasawa, Emi, Garcia-Horton, Viviana, Steffen, David R., Kandukuri, Prasanna L., Chaudhari, Vivek S., Jalundhwala, Yash J., Bao, Yanjun, Kukreja, Pavnit, Isaacson, Stuart H.
Publicado 2022

The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in England

por Chaudhuri, K. Ray, Pickard, A. Simon, Alobaidi, Ali, Jalundhwala, Yash J., Kandukuri, Prasanna L., Bao, Yanjun, Sus, Julia, Jones, Glynn, Ridley, Christian, Oddsdottir, Julia, Najle-Rahim, Seyavash, Madin-Warburton, Matthew, Xu, Weiwei, Schrag, Anette
Publicado 2022

Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries

por Malaty, Irene A., Martinez-Martin, Pablo, Chaudhuri, K. Ray, Odin, Per, Skorvanek, Matej, Jimenez-Shahed, Joohi, Soileau, Michael J., Lindvall, Susanna, Domingos, Josefa, Jones, Sarah, Alobaidi, Ali, Jalundhwala, Yash J., Kandukuri, Prasanna L., Onuk, Koray, Bergmann, Lars, Femia, Samira, Lee, Michelle Y., Wright, Jack, Antonini, Angelo
Publicado 2022

Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease: Real-World Evidence From G7 Countries

por Antonini, Angelo, Pahwa, Rajesh, Odin, Per, Henriksen, Tove, Soileau, Michael J., Rodriguez-Cruz, Ramon, Isaacson, Stuart H., Merola, Aristide, Lindvall, Susanna, Domingos, Josefa, Alobaidi, Ali, Jalundhwala, Yash J., Kandukuri, Prasanna L., Parra, Juan Carlos, Kukreja, Pavnit K., Onuk, Koray, Bergmann, Lars, Pike, James, Ray Chaudhuri, K.
Publicado 2022